RESUMEN
Antibiotic resistance amongst microbial pathogens is a mounting serious issue in researchers and physicians. Various alternatives to overcome the multidrug-resistant bacterial infections are under search, and biofilm growth inhibition is one of them. In this investigation, a polymeric drug delivery system loaded with multi-serratial drugs to improve the delivery of drugs against urinary tract infection causative Serratia marcescens. The chitosan grafted pyromellitic dianhydride - cysteine (CS-g-PMDA-CYS) was conjugated with AuNPs by using the -SH group of CYS and RF (rifampicin) and INH (isoniazid) were loaded in AuNPs-fused CS-g-PMDA-CYS system. Several physicochemical techniques characterized this fabricated AuNPs/RF/INH/CS-g-PMDA-CYS system. The successful encapsulation of RF and INH in AuNPs-fused CS-g-PMDA-CYS polymer had confirmed, and it observed the loading capacity for RF and INH was 9.02% and 13.12%, respectively. The in vitro drug discharge pattern was perceived high in pH 5.5 compared with pH 7.4. The AuNPs/RF/INH/CS-g-PMDA-CYS escalates 74% of Caenorhabditis elegans survival during Serratia marcescens infection by aiming biofilm development and virulence in S. marcescens. Author postulate that the fabricated system is a promising drug carrier and delivery system for inhibition of multidrug-resistant bacterias like S. marcescens.
Asunto(s)
Antibacterianos/administración & dosificación , Sistemas de Liberación de Medicamentos/métodos , Farmacorresistencia Bacteriana Múltiple/efectos de los fármacos , Compuestos de Oro/administración & dosificación , Nanopartículas del Metal/administración & dosificación , Serratia marcescens/efectos de los fármacos , Animales , Antibacterianos/química , Benzoatos/administración & dosificación , Benzoatos/síntesis química , Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/microbiología , Caenorhabditis elegans/fisiología , Quitosano/administración & dosificación , Quitosano/síntesis química , Cisteína/administración & dosificación , Cisteína/síntesis química , Farmacorresistencia Bacteriana Múltiple/fisiología , Compuestos de Oro/síntesis química , Nanopartículas del Metal/química , Pruebas de Sensibilidad Microbiana/métodos , Infecciones por Serratia/tratamiento farmacológico , Serratia marcescens/fisiología , Infecciones Urinarias/tratamiento farmacológico , Difracción de Rayos X/métodosRESUMEN
Methicillin-resistant Staphylococcus aureus (MRSA) is an extensive origin of nosocomial infections that are very much challenging as well as complicated to eradicate mostly due to their strong resistance against all existing antibiotic therapies. Here the chitosan-grafted-polycaprolactone/maleic anhydride-pyrazinamide (CS-g-PCL/MA-PZA) polymeric drug carrier constructed via dialysis for anti-MRSA drugs like rifampicin (RF) and pyrazinamide (PZA) delivery. Nearly 200 nm size of the spherical particle with -20.04 mV of zeta potential observed. The cumulative PZA and RF releases from the carrier were observed 83.25% and 76.54% respectively in pH 5.5, and the in vitro drug release profile demonstrates that the fabricated micelle was pH-responsive. For the intestinal colonization, an in vivo assay performed using C. elegans, and the CS-g-PCL/MA-PZA/RF micelles treated worms generally belong to the weakly colonized category. Therefore, the study revealed that CS-g-PCL/MA-PZA/RF micelle could be a promising approach for therapeutic applications to achieve efficient anti-MRSA drug delivery.
RESUMEN
Here, we focus on the fabrications of an osteosarcoma implant for bone repair via the development of a hydroxyapatite/κ-carrageenan-maleic anhydride/casein with doxorubicin (HAP/κ-CA-MA-CAS/DOX) composite-deposited titanium (Ti) plate. The HAP/κ-CA-MA-CAS/DOX material was coated on the Ti plate through the EPD method (electrophoretic deposition), applying direct current (DC) signals to deposit the composite on the surface of the Ti plate. The physicochemical and morphological possessions and biocompatibility in vitro of the prepared nanocomposite were examined to assess its prospective effectiveness for purposes of bone regeneration. Excellent biocompatibility and elevated osteoconductivity were confirmed using MG63 osteoblast-like cells. In vivo studies were performed at tibia sites in Wistar rats, and rapid bone regeneration was detected at four weeks in defective bone. Overall, the studies demonstrate that the HAP/κ-CA-MA-CAS/DOX composite enhances the biocompatible and cell-stimulating biointerface of Ti metallic implants. As such, HAP/κ-CA-MA-CAS/DOX implants are viable prospects for osteosarcoma-affected bone regeneration.
Asunto(s)
Durapatita , Titanio , Animales , Carragenina , Caseínas , Materiales Biocompatibles Revestidos , Doxorrubicina , Anhídridos Maleicos , Estudios Prospectivos , Ratas , Ratas WistarRESUMEN
Biocompatible polymers and ceramic materials have been identified as vital components to fabricate drug delivery and tissue engineering applications because of their high drug loading capability, sustained release and higher mechanical strength with remarkable in-vivo bioavailability. In the present work, initially we designed κ-carrageenan grafted with maleic anhydride and then reacted it with isoniazid drug (κ-Car-MA-INH). The polymeric system was cross linked with nanohydroxyapatite (NHAP) via electrostatic interaction followed by the addition of rifampicin (RF) and loaded to fabricate κ -Car-MA-INH/NHAP/RF nanocomposites. The chemical modification and interaction of drug with the polymeric-ceramic system were characterised by Fourier Transform Infrared spectroscopy (FT-IR). The zeta potential of the κ -Car-MA-INH/NHAP/RF nanocomposite was observed to be -20.04â¯mV using Zetasizer. The in vitro drug release studies demonstrated that the nanocomposite releases 76% of RF and 82% of INH in 12â¯days at pH 5.5. Scanning Electron Microscope analysis revealed the structural deformation of Staphylococcus aureus and Klebsiella pneumoniae upon treatment with this nanocomposite. By using ex-vivo studies combined with physio-chemical characterization methods on the erythrocytes, L929 and MG-63 cell lines, this composite was found to be biocompatible, non-cytotoxic and inducing cell proliferation with less significant hemolysis. Thus, our modified drug delivery nanocomposites afforded higher drug bioavailability with large potential for fabrication as long-acting drug delivery nanocomposites, especially with hydrophobic drugs inducing the growth of osteoblastic bone cells.
Asunto(s)
Antituberculosos , Sistemas de Liberación de Medicamentos , Durapatita , Isoniazida , Nanocompuestos , Rifampin , Animales , Antituberculosos/administración & dosificación , Antituberculosos/química , Carragenina/administración & dosificación , Carragenina/química , Línea Celular , Liberación de Fármacos , Durapatita/administración & dosificación , Durapatita/química , Eritrocitos/efectos de los fármacos , Hemólisis/efectos de los fármacos , Humanos , Isoniazida/administración & dosificación , Isoniazida/química , Klebsiella pneumoniae/efectos de los fármacos , Macrófagos/efectos de los fármacos , Anhídridos Maleicos/administración & dosificación , Anhídridos Maleicos/química , Ratones , Nanocompuestos/administración & dosificación , Nanocompuestos/química , Osteoblastos/efectos de los fármacos , Osteomielitis/tratamiento farmacológico , Regeneración , Rifampin/administración & dosificación , Rifampin/química , Staphylococcus aureus/efectos de los fármacos , Tuberculosis/tratamiento farmacológicoRESUMEN
The potential of polymeric micelles constructed by coalescing natural and synthetic polymers for tuberculosis (TB) treatment was evaluated in this work. We designed a polymeric micelle to improve the delivery of anti-TB drugs (rifampicin [RF] and isoniazid [INH]). The polymeric core was synthesized in the following order: initially chitosan (CS) was grafted with polycaprolactone (PCL) to form CS-g-PCL followed by amide bond formation with maleic anhydride-isoniazid (MA-INH); finally, CS-g-PCL was conjugated with the MA-INH moiety to form the CS-g-PCL/MA-INH polymeric core. Another anti-TB drug, RF, was loaded onto CS-g-PCL/MA-INH through dialysis. The changes in the nature of functional groups and crystallinity were investigated by Fourier transform infrared spectroscopy and X-ray diffraction analysis, respectively. The shape and size of CS-g-PCL/MA-INH and RF-CS-g-PCL/MA-INH were analyzed by dynamic light scattering, scanning electron microscopy, and transmission electron microscopy. The cumulative drug release profiles were measured by UV-visible spectrophotometry and HPLC analysis. The antimicrobial activity of the loaded micelles was evaluated by finding the minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and bacterial cell rupture analyses. The nontoxic nature of the micelles was assessed by ex vivo studies on U937 and L929 cell lines and erythrocytes by performing an MTT assay, apoptosis assay, and hemolysis assay. Ex vivo cellular uptake and in vivo internalization of the INH- and RF-containing micelles were tested on U937 cells and zebrafish using fluorescence microscopy analysis. All of the observations indicate that the multi-TB drug-loaded polymeric micelle is a safe and effective system for the delivery of anti-TB drugs without affecting the mycobactericidal activity.
RESUMEN
Natural polymer guar gum has one of the highest viscosities in water solution and hence, these are significantly used in pharmaceutical applications. Guar gum inter-connected micelles as a new carrier has been developed for poor water soluble rifampicin drug. The hydrogel inter-connected micelle core was formulated as a hydrophilic inner and hydrophobic outer core by using guar gum/chitosan/polycaprolactone and the carrier interaction with rifampicin was confirmed by FT-IR. The morphological observations were carried out through TEM, SEM and AFM analysis. The encapsulation efficiency and in-vitro drug release behavior of prepared hydrogel based micelle system was analyzed by UV-vis spectrometry. The anti-bacterial activity against K. pneumoniae and S. aureus was studied by observing their ruptured surface by SEM. The cytotoxicity study reveals that the pure polymeric system has no toxic effect whereas drug loaded ones showed superior activity against THP-1 cells. From the cell apoptosis analyses, the apoptosis was carried out in a time dependent manner. The cell uptake behavior was also observed in THP-1 cells which indicate that the hydrogel based micelle system is an excellent material for the mucoadhesive on intracellular alveolar macrophage treatment.
Asunto(s)
Antibióticos Antituberculosos/farmacología , Portadores de Fármacos/química , Hidrogeles/química , Micelas , Polímeros/química , Rifampin/farmacología , Animales , Antibióticos Antituberculosos/química , Apoptosis/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Quitosano/análogos & derivados , Quitosano/síntesis química , Quitosano/toxicidad , Chlorocebus aethiops , Portadores de Fármacos/síntesis química , Portadores de Fármacos/toxicidad , Liberación de Fármacos , Galactanos/síntesis química , Galactanos/química , Galactanos/toxicidad , Humanos , Hidrogeles/síntesis química , Hidrogeles/toxicidad , Klebsiella pneumoniae/efectos de los fármacos , Mananos/síntesis química , Mananos/química , Mananos/toxicidad , Gomas de Plantas/síntesis química , Gomas de Plantas/química , Gomas de Plantas/toxicidad , Poliésteres/síntesis química , Poliésteres/química , Poliésteres/toxicidad , Polímeros/síntesis química , Polímeros/toxicidad , Rifampin/química , Staphylococcus aureus/efectos de los fármacos , Células VeroRESUMEN
Polysaccharides are increasingly used as biodegradable nanocarrier to selectively deliver therapeutic agents to specific cells. In this study, maleate gellan gum (MA-GG) formed by addition of free radical polymerizable groups, which can be polymerized presence of acetone to design biodegradable three-dimensional networks, were synthesized by esterification. Natural silk sericin was grafted over the maleate gellan gum surface. Maleate Gellan Gum- Silk Sericin-Chitosan (MA-GG-SS-CS) nanocomposites loaded with rifampicin (RF) and pyrazinamide (PZA) to overcome the problems associated with Tuberculosis (TB) therapy. The pH responsive behavior of gellan gum nanocomposites was reposed by silk sericin and exhibited sustained release of 79% RF and 82% PZA for 120â¯h at pHâ¯4.0. The designed formulations shows higher antimycobacterial activity and rapid delivery of drugs at TB infected macrophage. Nanomaterial effectively aggregated and internalized into the bacterial cells and MH-S cells. Dual drug release inside the cells makes damage in the cell membrane. Green nanocomposites studies pave the way for important use of macromolecules in pulmonary delivery TB drugs.
Asunto(s)
Antibacterianos/farmacología , Quitosano/química , Mycobacterium tuberculosis/efectos de los fármacos , Nanocompuestos/química , Polisacáridos Bacterianos/química , Sericinas/química , Antibacterianos/química , Antibacterianos/metabolismo , Transporte Biológico , Línea Celular , Humanos , Concentración de Iones de Hidrógeno , Maleatos/química , Ensayo de Materiales , Mycobacterium tuberculosis/citologíaRESUMEN
Recently, drug functionalized biodegradable polymers have been appreciated to be imperative to fabricate multi-drug delivery nanosystems for sustainable drug release. In this work, amphiphilic chitosan-grafted-(cetyl alcohol-maleic anhydride-pyrazinamide) (CS-g-(CA-MA-PZA)) was synthesized by multi-step reactions. The incorporation of rifampicin (RF) and entrapment of silver nanoparticles (Ag NPs) on CS-g-(CA-MA-PZA) polymer was carried out by dialysis technique. From the FT-IR experiment, the polymer modification, incorporation of drugs and the entrapment of Ag NPs on micelles were confirmed. The surface morphology of Ag NPs, polymeric system and drug loaded micelles was described by SEM, TEM and AFM techniques. In addition, the controlled release behaviour of CS-g-(CA-MA-PZA) micelles was studied by UV-Vis spectroscopy. In vitro cell viability, cell apoptosis and cellular uptake experiments shows that multi-drug delivery system could enhance the biocompatibility and higher the cytotoxicity effect on the cells. Since the prepared amphiphilic polymeric micelles exhibit spotty features and the system is a promising strategy for a novel candidate for immediate therapeutically effects for alveolar macrophages.
Asunto(s)
Antituberculosos/administración & dosificación , Quitosano , Portadores de Fármacos , Sistemas de Liberación de Medicamentos , Nanopartículas del Metal , Polímeros , Plata , Antituberculosos/química , Apoptosis , Línea Celular , Quitosano/química , Portadores de Fármacos/química , Composición de Medicamentos , Dispersión Dinámica de Luz , Alcoholes Grasos/química , Humanos , Anhídridos Maleicos/química , Nanopartículas del Metal/química , Nanopartículas del Metal/ultraestructura , Micelas , Microscopía de Fuerza Atómica , Polímeros/química , Plata/química , Espectroscopía Infrarroja por Transformada de Fourier , Difracción de Rayos XRESUMEN
We have developed a nano drug delivery system for the treatment of tuberculosis (TB) using rifampicin (RF) encapsulated in poly(ester amide)s nanoparticles (PEA-RF-NPs), which are biocompatible polymers. In this study, biodegradable amino acid based poly(ester amide)s (PEAs) were synthesized by the poly condensation reaction and RF-loaded NPs were fabricated by the dialysis method. The surface morphology and in-vitro drug release efficiency were examined. The effect of time and temperature on the cellular uptake of PEA-RF-NPs in NR8383 cells was evaluated. Fluorescence microscopic results of PEA-RF-NPs from NR8383 cell lines suggest its potential application in treating TB. The antibacterial activity of RF against Mycobacterium smegmatis was also evaluated. Based on these results, this approach provides a new means for controlled and efficient release of RF using the PEA-NPs delivery system and is promising for the treatment of TB.